SorafenibNeutropenia and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25218-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：482 / 482

相关论文

共 50 条

[41] GadobutrolNeurotoxicity following an off label use: case report
Reactions Weekly, 2019, 1773 (1) : 169 - 169
[42] DexamethasoneCytomegalovirus infection and off label use: case report
Reactions Weekly, 2022, 1924 (1) : 188 - 188
[43] PembrolizumabEosinophilic fasciitis and off label use: case report
Reactions Weekly, 2021, 1872 (1) : 414 - 414
[44] MetreleptinHypoglycaemia following off label use: case report
Reactions Weekly, 2022, 1924 (1) : 287 - 287
[45] Multiple drugsVomiting and off label use: case report
Reactions Weekly, 2025, 2044 (1) : 279 - 279
[46] Acetylcysteine/paracetamolOverdose and off label use: case report
Reactions Weekly, 2022, 1932 (1) : 17 - 17
[47] CidofovirTubulopathy following off label use: case report
Reactions Weekly, 2018, 1731 (1) : 81 - 81
[48] DexmedetomidineHypotension and off-label use: case report
Reactions Weekly, 2019, 1749 (1) : 172 - 172
[49] AzithromycinCardiotoxicity and Off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 100 - 100
[50] LomitapideDiarrhoea following off label use: case report
Reactions Weekly, 2019, 1763 (1) : 214 - 214

← 1 2 3 4 5 →